Cornelissen R - Search Results

1

Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients.

Lievense LA, Bezemer K, Cornelissen R, Kaijen-Lambers ME, Hegmans JP, Aerts JG. Lievense LA, et al. Among authors: cornelissen r. Lung Cancer. 2017 May;107:36-40. doi: 10.1016/j.lungcan.2016.04.015. Epub 2016 Apr 27. Lung Cancer. 2017. PMID: 27168021

2

Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinoma.

Cornelissen R, Senan S, Antonisse IE, Liem H, Tan YK, Rudolphus A, Aerts JG. Cornelissen R, et al. Radiat Oncol. 2007 Jan 3;2:2. doi: 10.1186/1748-717X-2-2. Radiat Oncol. 2007. PMID: 17201913 Free PMC article.

3

New roads open up for implementing immunotherapy in mesothelioma.

Cornelissen R, Heuvers ME, Maat AP, Hendriks RW, Hoogsteden HC, Aerts JG, Hegmans JP. Cornelissen R, et al. Clin Dev Immunol. 2012;2012:927240. doi: 10.1155/2012/927240. Epub 2012 Jun 24. Clin Dev Immunol. 2012. PMID: 22778767 Free PMC article. Review.

4

Dendritic cell-based immunotherapy in mesothelioma.

Cornelissen R, Lievense LA, Heuvers ME, Maat AP, Hendriks RW, Hoogsteden HC, Hegmans JP, Aerts JG. Cornelissen R, et al. Immunotherapy. 2012 Oct;4(10):1011-22. doi: 10.2217/imt.12.108. Immunotherapy. 2012. PMID: 23148753 Review.

5

Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.

Heuvers ME, Aerts JG, Cornelissen R, Groen H, Hoogsteden HC, Hegmans JP. Heuvers ME, et al. Among authors: cornelissen r. BMC Cancer. 2012 Dec 5;12:580. doi: 10.1186/1471-2407-12-580. BMC Cancer. 2012. PMID: 23217146 Free PMC article. Review.

6

Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma.

Cornelissen R, Lievense LA, Maat AP, Hendriks RW, Hoogsteden HC, Bogers AJ, Hegmans JP, Aerts JG. Cornelissen R, et al. PLoS One. 2014 Sep 5;9(9):e106742. doi: 10.1371/journal.pone.0106742. eCollection 2014. PLoS One. 2014. PMID: 25192022 Free PMC article.

7

Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma.

Cornelissen R, Lievense LA, Robertus JL, Hendriks RW, Hoogsteden HC, Hegmans JP, Aerts JG. Cornelissen R, et al. Lung Cancer. 2015 Jun;88(3):332-7. doi: 10.1016/j.lungcan.2015.03.013. Epub 2015 Mar 21. Lung Cancer. 2015. PMID: 25843042

8

Is the patient with mesothelioma without hope?

Maat AP, Cornelissen R, Bogers AJ, Takkenberg JJ. Maat AP, et al. Among authors: cornelissen r. Future Oncol. 2015;11(24 Suppl):11-4. doi: 10.2217/fon.15.184. Future Oncol. 2015. PMID: 26638916

9

Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma.

Cornelissen R, Hegmans JP, Maat AP, Kaijen-Lambers ME, Bezemer K, Hendriks RW, Hoogsteden HC, Aerts JG. Cornelissen R, et al. Am J Respir Crit Care Med. 2016 May 1;193(9):1023-31. doi: 10.1164/rccm.201508-1573OC. Am J Respir Crit Care Med. 2016. PMID: 26652184

10

Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell Suppression.

Lievense LA, Cornelissen R, Bezemer K, Kaijen-Lambers ME, Hegmans JP, Aerts JG. Lievense LA, et al. Among authors: cornelissen r. J Thorac Oncol. 2016 Oct;11(10):1755-64. doi: 10.1016/j.jtho.2016.06.021. Epub 2016 Jul 12. J Thorac Oncol. 2016. PMID: 27418106 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page